Long- and short-time immunological memory in different strains of mice given nasally an adjuvant-combined nasal influenza vaccine

被引:11
作者
Asanuma, Hideki
Fujihashi, Kohtaro
Miyakoshi, Takashi
Yoshikawa, Tomoki
Fujita-Yamaguchi, Yoko
Kojima, Naoya
Nakata, Munehiro
Suzuki, Yujiro
Tamura, Shin-Ichi
Kurata, Takeshi
Sata, Tetsutaro
机构
[1] Tokai Univ, Sch Engn, Dept Appl Biochem, Kanagawa 2591292, Japan
[2] Natl Inst Infect Dis, Dept Pathol, Tokyo 1628640, Japan
[3] Univ Alabama, Immunobiol Vaccine Ctr, Dept Pediat Dent, Birmingham, AL 35294 USA
[4] Kitasato Inst, Biol Res Ctr, Saitama 3640026, Japan
关键词
aged mice; mucosal immunity; influenza vaccine; nasal IgA; adjuvant;
D O I
10.1016/j.vaccine.2007.06.060
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Immunological memory induced by nasal immunization with adjuvant-combined influenza vaccine was analyzed in different ages and strains of mice. The memory activities were assessed by secondary nasal-wash IgA and serum IgG antibody (Ab) responses and protection against challenge infection with a lethal dose of influenza virus. Mice were primed with 0.1 mu g of vaccine and boosted with 0. 1 or 1.0 mu g vaccine I (short-term memory)- or 17 (long-term memory)-months later. Influenza-specific short-term memory responses in young adult BALB/c mice (2-month-old) were significantly higher than those of long-term memory activities in mice boosted at 19 months of age. However, those influenza-specific long-term memory responses provided protective immunity against influenza virus challenge and were higher than short-term memory in aged mice primed at 18-month-old and boosted I month later. These results show that the age at which initial nasal immunization is given is critically important in order to induce protective immunity in aged mice. Similar findings were noted in the C3H mouse strain; however, C57/BL/6 mice failed to induce influenza-specific immune responses in both young adult and aged mice. These results indicate that low doses of cholera toxin B subunit (supplemented with 0.2% of hole toxin) combined nasal vaccine may required further improvement in order to provide protective immunity in human use. (C) 2007Elsevier Ltd. All rights reserved.
引用
收藏
页码:6975 / 6980
页数:6
相关论文
共 22 条
  • [1] [Anonymous], 1986, OPTIONS CONTROL INFL
  • [2] Immune responses and protection in different strains of aged mice immunized intranasally with an adjuvant-combined influenza vaccine
    Asanuma, H
    Hirokawa, K
    Uchiyama, M
    Suzuki, Y
    Aizawa, C
    Kurata, T
    Sata, T
    Tamura, S
    [J]. VACCINE, 2001, 19 (28-29) : 3981 - 3989
  • [3] CHARACTERIZATION OF MOUSE NASAL LYMPHOCYTES ISOLATED BY ENZYMATIC EXTRACTION WITH COLLAGENASE
    ASANUMA, H
    INABA, Y
    AIZAWA, C
    KURATA, T
    TAMURA, SI
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1995, 187 (01) : 41 - 51
  • [4] BRANDRISS MW, 1981, AM REV RESPIR DIS, V124, P681
  • [5] ELSON CO, 1985, J IMMUNOL, V135, P930
  • [6] GHENDON Y, 1989, ADV EXP MED BIOL, V257, P37
  • [7] GIBBSON JH, 1981, COST EFFECTIVENESS I, P43
  • [8] THE EFFICACY OF INFLUENZA VACCINE IN ELDERLY PERSONS - A METAANALYSIS AND REVIEW OF THE LITERATURE
    GROSS, PA
    HERMOGENES, AW
    SACKS, HS
    LAU, J
    LEVANDOWSKI, RA
    [J]. ANNALS OF INTERNAL MEDICINE, 1995, 123 (07) : 518 - 527
  • [9] Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin
    Hashigucci, K
    Ogawa, H
    Ishidate, T
    Yamashita, R
    Kamiya, H
    Watanabe, K
    Hattori, N
    Sato, T
    Suzuki, Y
    Nagamine, T
    Aizawa, C
    Tamura, S
    Kurata, T
    Oya, A
    [J]. VACCINE, 1996, 14 (02) : 113 - 119
  • [10] HASHIGUCCI K, 1997, J JPN ASS INFECT DIS, V71, P153